Herpesviridae infections in newborns: Varicella zoster virus, herpes simplex virus, and cytomegalovirus

Pediatric Clinics of North America

Volumn 51, Issue 4, 2004, Pages 889-908

  Enright, Andrea M ^a   Prober, Charles G ^b  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR; VIDARABINE; VIRUS VACCINE;

CLINICAL FEATURE; CLINICAL TRIAL; CYTOMEGALOVIRUS; DOSE RESPONSE; EPIDEMIOLOGICAL DATA; FOLLOW UP; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HUMAN; IMMUNITY; INFANCY; INFANT; INFECTION PREVENTION; LONG TERM CARE; MONITORING; MORBIDITY; MORTALITY; MOTHER; NEWBORN; NEWBORN CARE; NEWBORN DISEASE; PERINATAL PERIOD; REVIEW; STANDARDIZATION; UTERUS; VACCINATION; VARICELLA ZOSTER VIRUS;

ANTIVIRAL AGENTS; CHICKENPOX; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HERPES SIMPLEX; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SYNDROME;

EID: 3242709734     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2004.03.005     Document Type: Review

References (122)

1. Prober C.G. Herpes simplex virus. Long S.S., Pickering L.K., Prober C.G. Principles and practice of pediatric infectious diseases. 2nd edition:2003;1032-1040 Churchill Livingstone, New York
2. Chartrand S.A. Varicella vaccine. Pediatr Clin North Am. 47:2000;373-394
3. Miller E., Cradock-Watson J.E., Ridehalgh M.K. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet. 2:1989;371-373
4. Enders G., Miller E., Cradock-Watson J., et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 343:1994;1548-1551
5. Paryani S.G., Arvin A.M. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med. 314:1986;1542-1546
6. Laforet L. Multiple congenital defects following maternal varicella. N Engl J Med. 236:1947;534-537
7. Pastuszak A.L., Levy M., Schick B., et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med. 330:1994;901-905
8. Jones K.L., Johnson K.A., Chambers C.D. Offspring of women infected with varicella during pregnancy: a prospective study. Teratology. 49:1994;29-32
9. Da Silva O., Hammerberg O., Chance G.W. Fetal varicella syndrome. Pediatr Infect Dis J. 9:1990;854-855
10. Bassett D.C. Varicella infection in pregnancy. N Engl J Med. 331:1994;482
11. Wheatley R., Morton R.E., Nicholson J. Chicken pox in mid-trimester pregnancy: always innocent? Dev Med Child Neurol. 38:1996;462-466
12. Ong C.L., Daniel M.L. Antenatal diagnosis of a porencephalic cyst in congenital varicella- zoster virus infection. Pediatr Radiol. 28:1998;94
13. Mouly F., Mirlesse V., Meritet J.F., et al. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol. 177:1997;894-898
14. Alkalay A.L., Pomerance J.J., Rimoin D.L. Fetal varicella syndrome. J Pediatr. 111:1987;320-323
15. Scharf A., Scherr O., Enders G., et al. Virus detection in the fetal tissue of a premature delivery with a congenital varicella syndrome. A case report. J Perinat Med. 18:1990;317-322
16. Higa K., Dan K., Manabe H. Varicella-zoster virus infections during pregnancy: hypothesis concerning the mechanisms of congenital malformations. Obstet Gynecol. 69:1987;214-222
17. Kent A., Paes B. Congenital varicella syndrome: a rare case of central nervous system involvement without dermatological features. Am J Perinatol. 17:2000;253-256
18. Harger J.H., Ernest J.M., Thurnau G.R., et al. Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women. Obstet Gynecol. 100:2002;260-265
19. Meyers J.D. Congenital varicella in term infants: risk reconsidered. J Infect Dis. 129:1974;215-217
20. DeNicola L.K., Hanshaw J.B. Congenital and neonatal varicella. J Pediatr. 94:1979;175-176
21. Holland P., Isaacs D., Moxon E.R. Fatal neonatal varicella infection. Lancet. 2:1986;1156
22. King S.M., Gorensek M., Ford-Jones E.L., et al. Fatal varicella-zoster infection in a newborn treated with varicella-zoster immunoglobulin. Pediatr Infect Dis. 5:1986;588-589
23. Prober C.G., Gershon A.A., Grose C., et al. Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J. 9:1990;865-869
24. van Der Zwet W.C., Vandenbroucke-Grauls C.M., van Elburg R.M., et al. Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer. Pediatrics. 109:2002;79-85
25. Centers for Disease Control Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 45:1996;1-25
26. Kavaliotis J. Acyclovir therapy in neonates [letter to editor]. J Pediatr. 119:1992;665
27. Williams H., Latif A., Morgan J., et al. Acyclovir in the treatment of neonatal varicella. J Infect. 15:1987;65-67
28. Gold W.L., Boulton J.E., Goldman C., et al. Management of varicella exposures in the neonatal intensive care unit. Pediatr Infect Dis J. 12:1993;954-955
29. Heuchan A.M., Isaacs D. The management of varicella-zoster virus exposure and infection in pregnancy and the newborn period. Australasian Subgroup in Paediatric Infectious Diseases of the Australasian Society for Infectious Diseases. Med J Aust. 174:2001;288-292
30. Whitley R.J., Kimberlin D.W., Roizman B. Herpes simplex viruses. Clin Infect Dis. 26:1998;541-553
31. Arvin A.M., Whitley R.J. Herpes simplex infections. Remington J.S., Klein J.O. Infectious diseases of the fetus and newborn infant. 5th edition:2001;425-446 W.B. Saunders Company, Philadelphia
32. Annunziato P.W., Gershon A. Herpes simplex virus infections. Pediatr Rev. 17:1996;415-423
33. Brown Z.A., Wald A., Morrow R.A., et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 289:2003;203-209
34. Prober C.G., Corey L., Brown Z.A., et al. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis. 15:1992;1031-1038
35. Whitley R.J. Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc Natl Acad Sci USA. 91:1994;2441-2447
36. Jacobs R.F. Neonatal herpes simplex virus infections. Semin Perinatol. 22:1998;64-71
37. Randolph A.G., Washington A.E., Prober C.G. Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs. JAMA. 270:1993;77-82
38. Gutierrez K.M., Falkovitz Halpern M.S., Maldonado Y., et al. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis. 180:1999;199-202
39. Stone K.M., Brooks C.A., Guinan M.E., et al. National surveillance for neonatal herpes simplex virus infections. Sex Transm Dis. 16:1989;152-156
40. Hutto C., Arvin A., Jacobs R., et al. Intrauterine herpes simplex virus infections. J Pediatr. 110:1987;97-101
41. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 108:2001;223-229
42. Whitley R., Arvin A., Prober C., et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 324:1991;444-449
43. Whitley R.J. Neonatal herpes simplex virus infections: is there a role for immunoglobulin in disease prevention and therapy? Pediatr Infect Dis J. 13:1994;432-438
44. Fleming D.T., McQuillan G.M., Johnson R.E., et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 337:1997;1105-1111
45. Kulhanjian J.A., Soroush V., Au D.S., et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med. 326:1992;916-920
46. Brown Z.A., Selke S., Zeh J., et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 337:1997;509-515
47. Corey L., Handsfield H.H. Genital herpes and public health: addressing a global problem. JAMA. 283:2000;791-794
48. Koutsky L.A., Stevens C.E., Holmes K.K., et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med. 326:1992;1533-1539
49. Binkin N.J., Koplan J.P., Cates W. Jr. Preventing neonatal herpes. The value of weekly viral cultures in pregnant women with recurrent genital herpes. JAMA. 251:1984;2816-2821
50. Brown Z.A., Benedetti J., Ashley R., et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med. 324:1991;1247-1252
51. Arvin A.M., Hensleigh P.A., Prober C.G., et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med. 315:1986;796-800
52. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 108:2001;230-238
53. American Academy of Pediatrics Herpes simplex. Pickering L.K. Red book 2003: report of the Committee on Infectious Diseases. 26th edition:2003;344-353 American Academy of Pediatrics, Elk Grove Village (IL)
54. Kimberlin D.W., Lakeman F.D., Arvin A.M., et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 174:1996;1162-1167
55. Troendle-Atkins J., Demmler G.J., Buffone G.J. Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction. J Pediatr. 123:1993;376-380
56. Weil A.A., Glaser C.A., Amad Z., Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction (PCR). Clin Infect Dis. 34:2002;1154-1157
57. Guffond T., Dewilde A., Lobert P.E., et al. Significance and clinical relevance of the detection of herpes simplex virus DNA by the polymerase chain reaction in cerebrospinal fluid from patients with presumed encephalitis. Clin Infect Dis. 18:1994;744-749
58. Diamond C., Mohan K., Hobson A., et al. Viremia in neonatal herpes simplex virus infections. Pediatr Infect Dis J. 18:1999;487-489
59. Ilona L.F., Pia O., Marianne F., et al. Detection of herpes simplex virus DNA in dried blood spots making a retrospective diagnosis possible. J Clin Virol. 26:2003;39-48
60. Kimberlin D., Powell D., Gruber W., et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a Phase I/II trial. Pediatr Infect Dis J. 15:1996;247-254
61. ACOG ACOG practice bulletin management of herpes in pregnancy. International J of Gyn & Obs. 68:2000;165-174
62. Rouse D.J., Stringer J.S. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am J Obstet Gynecol. 183:2000;400-406
63. Corey L., Langenberg A.G., Ashley R., et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA. 282:1999;331-340
64. Prober C.G. Introduction to Herpesviridae. Long S.S., Pickering L.K., Prober C.G. Principles and practice of pediatric infectious diseases. 2nd edition:2003;1031-1032 Churchill Livingston, Philadelphia
65. Pass R. Cytomegalovirus. Long S.S., Pickering L.K., Prober C.G. Principles and practice of pediatric infectious diseases. 2nd edition:2003;1050-1058 Churchill Livingston, Philadelphia
66. American Academy of Pediatrics Cytomegalovirus infection. Pickering L.K. Red book 2003: report of the Committee on Infectious Diseases. 26th edition:2003;259-262 American Academy of Pediatrics, Elk Grove Village (IL)
67. Stagno S. Cytomegalovirus. Remington J.S., Klein J.O. Infectious diseases of the fetus and newborn infant. 5th edition:2001;389-424 W.B. Saunders Company, Philadelphia
68. Halwachs-Baumann G., Genser B., Danda M., et al. Screening and diagnosis of congenital cytomegalovirus infection: a 5-y study. Scand J Infect Dis. 32:2000;137-142
69. Stagno S., Pass R.F., Cloud G., et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA. 256:1986;1904-1908
70. Fowler K.B., Stagno S., Pass R.F. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA. 289:2003;1008-1011
71. Boppana S.B., Fowler K.B., Britt W.J., et al. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics. 104:1999;55-60
72. Boppana S.B., Rivera L.B., Fowler K.B., et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 344:2001;1366-1371
73. Enders G., Bader U., Lindemann L., et al. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn. 21:2001;362-377
74. Lipitz S., Achiron R., Zalel Y., et al. Outcome of pregnancies with vertical transmission of primary cytomegalovirus infection. Obstet Gynecol. 100:2002;428-433
75. Revello M.G., Zavattoni M., Furione M., et al. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis. 186:2002;553-557
76. Pass R.F., Stagno S., Myers G.J., et al. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics. 66:1980;758-762
77. Williamson W.D., Demmler G.J., Percy A.K., et al. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics. 90:1992;862-866
78. Boppana S.B., Fowler K.B., Vaid Y., et al. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics. 99:1997;409-414
79. Fowler K.B., Dahle A.J., Boppana S.B., et al. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr. 135:1999;60-64
80. Rivera L.B., Boppana S.B., Fowler K.B., et al. Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics. 110:2002;762-767
81. Williamson W.D., Desmond M.M., LaFevers N., et al. Symptomatic congenital cytomegalovirus. Disorders of language, learning, and hearing. Am J Dis Child. 136:1982;902-905
82. Noyola D.E., Demmler G.J., Williamson W.D., et al. Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group. Pediatr Infect Dis J. 19:2000;505-510
83. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, American Speech-Language-Hearing Association, and Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Pediatrics. 106:2000;798-817
84. Fowler K.B., McCollister F.P., Dahle A.J., et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 130:1997;624-630
85. Hanshaw J.B., Scheiner A.P., Moxley A.W., et al. School failure and deafness after "silent" congenital cytomegalovirus infection. N Engl J Med. 295:1976;468-470
86. Barbi M., Binda S., Caroppo S., et al. A wider role for congenital cytomegalovirus infection in sensorineural hearing loss. Pediatr Infect Dis J. 22:2003;39-42
87. Hicks T., Fowler K., Richardson M., et al. Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr. 123:1993;779-782
88. Conboy T.J., Pass R.F., Stagno S., et al. Intellectual development in school-aged children with asymptomatic congenital cytomegalovirus infection. Pediatrics. 77:1986;801-806
89. Ivarsson S.A., Lernmark B., Svanberg L. Ten-year clinical, developmental, and intellectual follow-up of children with congenital cytomegalovirus infection without neurologic symptoms at one year of age. Pediatrics. 99:1997;800-803
90. Hodinka R. Human cytomegalovirus. Murray P., Baron E.J., Jorgensen J.H., et al. Manual of clinical microbiology. vol. 2:2003;1309-1310 ASM Press, Washington DC
91. Balcarek K.B., Warren W., Smith R.J., et al. Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva. J Infect Dis. 167:1993;1433-1436
92. Warren W.P., Balcarek K., Smith R., et al. Comparison of rapid methods of detection of cytomegalovirus in saliva with virus isolation in tissue culture. J Clin Microbiol. 30:1992;786-789
93. Stirk P.R., Griffiths P.D. Use of monoclonal antibodies for the diagnosis of cytomegalovirus infection by the detection of early antigen fluorescent foci (DEAFF) in cell culture. J Med Virol. 21:1987;329-337
94. Troendler A.J., Demmler G.J., Williamson W.D., et al. Polymerase chain reaction to detect cytomegalovirus DNA in the cerebrospinal fluid of neonates with congenital infection. J Infect Dis. 169:1994;1334-1337
95. Revello M.G., Zavattoni M., Furione M., et al. Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses. J Clin Microbiol. 37:1999;3350-3352
96. Stagno S., Reynolds D.W., Pass R.F., et al. Breast milk and the risk of cytomegalovirus infection. N Engl J Med. 302:1980;1073-1076
97. Hamprecht K., Witzel S., Maschmann J., et al. Transmission of cytomegalovirus infection through breast milk in term and preterm infants. The role of cell free milk whey and milk cells. Adv Exp Med Biol. 478:2000;231-239
98. Dworsky M., Yow M., Stagno S., et al. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics. 72:1983;295-299
99. Maschmann J., Hamprecht K., Dietz K., et al. Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clin Infect Dis. 33:2001;1998-2003
100. Vochem M., Hamprecht K., Jahn G., et al. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J. 17:1998;53-58
101. Hamprecht K., Maschmann J., Vochem M., et al. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet. 357:2001;513-518
102. Hayes K., Danks D.M., Gibas H., et al. Cytomegalovirus in human milk. N Engl J Med. 287:1972;177-178
103. Asanuma H., Numazaki K., Nagata N., et al. Role of milk whey in the transmission of human cytomegalovirus infection by breast milk. Microbiol Immunol. 40:1996;201-204
104. Alford C. Breast milk transmission of cytomegalovirus (CMV) infection. Adv Exp Med Biol. 310:1991;293-299
105. Yasuda A., Kimura H., Hayakawa M., et al. Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay. Pediatrics. 111:2003;1333-1336
106. Cheeseman S.H., McGraw B.R. Studies on cytomegalovirus in human milk. J Infect Dis. 148:1983;615-616
107. Friis H., Andersen H.K. Rate of inactivation of cytomegalovirus in raw banked milk during storage at -20 degrees C and pasteurisation. Br Med J (Clin Res Ed). 285:1982;1604-1605
108. Dworsky M., Stagno S., Pass R.F., et al. Persistence of cytomegalovirus in human milk after storage. J Pediatr. 101:1982;440-443
109. Welsh J.K., Arsenakis M., Coelen R.J., et al. Effect of antiviral lipids, heat, and freezing on the activity of viruses in human milk. J Infect Dis. 140:1979;322-328
110. Lawrence R. Breastfeeding: a guide for the medical professional. St. Louis (MO): Mosby; 1999. p. 87,151-158,174,208,601-611,484-485
111. Goldblum R.M., Dill C.W., Albrecht T.B., et al. Rapid high-temperature treatment of human milk. J Pediatr. 104:1984;380-385
112. Yeager A.S. Transfusion-acquired cytomegalovirus infection in newborn infants. Am J Dis Child. 128:1974;478-483
113. Yeager A.S., Grumet F.C., Hafleigh E.B., et al. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr. 98:1981;281-287
114. Gilbert G.L., Hayes K., Hudson I.L., et al. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet. 1:1989;1228-1231
115. Sandler S.G., Grumet F.C. Posttransfusion cytomegalovirus infections. Pediatrics. 69:1982;650-653
116. Przepiorka D., LeParc G.F., Werch J., et al. Prevention of transfusion-associated cytomegalovirus infection. Practice parameter. American Society of Clinical Pathologists. Am J Clin Pathol. 106:1996;163-169
117. Whitley R.J., Cloud G., Gruber W., et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a Phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 175:1997;1080-1086
118. Kimberlin D., Lin C.Y., Sanchez P.J., et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized controlled trial. J Pediatric. 143(1):2003;16-25
119. The Jordan report 2000: accelerated development of diseases. 2000;National Institute of Allergy & Infectious Diseases
120. Adler S.P., Starr S.E., Plotkin S.A., et al. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis. 171:1995;26-32
121. Plotkin S.A. Vaccination against cytomegalovirus, the changeling demon. Pediatr Infect Dis J. 18:1999;313-325
122. Pass R.F., Duliege A.M., Boppana S., et al. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J Infect Dis. 180:1999;970-975